Insider · CIK 0001397607

Schinazi Raymond F

Reports to the SEC for 3 companies · ATLANTA, GA

sec.gov

Transactions

Companies

Filings

CIK

0001397607

Forms 4 and 5

Insider transactions

35 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-05-10	DTILPRECISION BIOSCIENCES INC · Stock Option (Right to Buy)A Award	Director	AAward	+157K sh	—	—	156,951
2021-05-10	DTILPRECISION BIOSCIENCES INC · Stock Option (Right to Buy)A Award	Director	AAward	+32.8K sh	—	—	32,800
2021-05-04	COCPCocrystal Pharma, Inc.S Sale	10% Owner	SSale	−575K sh	$2.95	−$1.7M	7,674,960
2020-05-13	DTILPRECISION BIOSCIENCES INC · Stock Option (Right to Buy)A Award	Director	AAward	+41K sh	—	—	41,038
2019-10-25	COCPCocrystal Pharma, Inc.P Purchase	10% Owner	PPurchase	+7,906 sh	$1.15	+$9,091.9	9,257,863
2019-10-24	COCPCocrystal Pharma, Inc.P Purchase	10% Owner	PPurchase	+5,094 sh	$1.15	+$5,858.1	9,249,957
2019-10-23	COCPCocrystal Pharma, Inc.P Purchase	10% Owner	PPurchase	+3,935 sh	$1.04	+$4,086.891	9,244,863
2019-04-01	DTILPRECISION BIOSCIENCES INCC Conversion	Director	CConversion	+36.9K sh	$13.60	+$502K	36,946
2019-04-01	DTILPRECISION BIOSCIENCES INCC Conversion	Director	CConversion	+56.1K sh	—	—	93,048
2019-04-01	DTILPRECISION BIOSCIENCES INC · Convertible Promissory NoteC Conversion	Director	CConversion	—	—	—	0
2019-04-01	DTILPRECISION BIOSCIENCES INC · Series B Preferred StockC Conversion	Director	CConversion	−120K sh	—	—	0
2019-03-27	DTILPRECISION BIOSCIENCES INC · Stock Option (Right to Buy)A Award	Director	AAward	+34.5K sh	—	—	34,544
2019-03-27	DTILPRECISION BIOSCIENCES INC · Convertible Promissory NoteJ Other	Director	JOther	—	$500000.00	—	—
2018-09-21	COCPCocrystal Pharma, Inc. · Stock Options (Right to Buy)A Award	10% Owner	AAward	+50K sh	—	—	50,000
2018-05-10	COCPCocrystal Pharma, Inc.M Exercise/Conversion	10% Owner	MExercise/Conversion	+263K sh	$1.90	+$500K	985,384
2018-05-10	COCPCocrystal Pharma, Inc.A Award	10% Owner	AAward	+10.2K sh	$1.90	+$19.4K	995,593
2018-05-10	COCPCocrystal Pharma, Inc. · 8% Convertible NoteD Disposition to Issuer	10% Owner	DDisposition to Issuer	−61.7K sh	$500000.00	−$30.9B	61,728
2018-05-10	COCPCocrystal Pharma, Inc. · 8% Convertible NoteA Award	10% Owner	AAward	+263K sh	$500000.00	+$132B	263,158
2018-05-10	COCPCocrystal Pharma, Inc. · 8% Convertible NoteM Exercise/Conversion	10% Owner	MExercise/Conversion	−263K sh	$500000.00	−$132B	263,158
2018-05-03	COCPCocrystal Pharma, Inc.A Award	10% Owner	AAward	+421K sh	$1.90	+$799K	722,226
2017-11-24	COCPCocrystal Pharma, Inc. · 8% Convertible NoteA Award	10% Owner	AAward	+1.85M sh	$500000.00	+$926B	1,851,851
2017-07-11	COCPCocrystal Pharma, Inc.M Exercise/Conversion	10% Owner	MExercise/Conversion	+1.71M sh	$0.05	+$80.2K	277,227,831
2017-07-11	COCPCocrystal Pharma, Inc. · Stock Options (Right to Buy)M Exercise/Conversion	10% Owner	MExercise/Conversion	−1.71M sh	—	—	0
2017-04-20	COCPCocrystal Pharma, Inc.A Award	10% Owner	AAward	+4.17M sh	$0.24	+$1M	9,044,717
2016-09-01	COCPCocrystal Pharma, Inc.P Purchase	10% Owner	PPurchase	+4.88M sh	$0.41	+$2M	4,878,050
2016-03-15	COCPCocrystal Pharma, Inc.P Purchase	10% Owner	PPurchase	+2.94M sh	$0.51	+$1.5M	275,520,853
2015-04-21	COCPCocrystal Pharma, Inc.P Purchase	10% Owner	PPurchase	+3.46M sh	$0.92	+$3.19M	272,579,677
2015-04-13	COCPCocrystal Pharma, Inc. · Stock options (Right to buy)A Award	10% Owner	AAward	+350K sh	—	—	350,000
2015-03-03	COCPCocrystal Pharma, Inc.M Exercise/Conversion	10% Owner	MExercise/Conversion	+269M sh	—	—	269,114,822
2015-03-03	COCPCocrystal Pharma, Inc. · Series A Convertible Preferred StockM Exercise/Conversion	10% Owner	MExercise/Conversion	−790K sh	—	—	0
2014-11-25	COCPCocrystal Pharma, Inc. · Series A Convertible Preferred StockA Award	10% Owner	AAward	+799K sh	—	—	798,747
2014-11-25	COCPCocrystal Pharma, Inc. · Stock Options (Right to Buy)A Award	10% Owner	AAward	+1.71M sh	—	—	1,706,978
2014-11-25	COCPCocrystal Pharma, Inc. · Stock Options (Right to Buy)A Award	10% Owner	AAward	+1.71M sh	—	—	1,706,978
2014-11-25	COCPCocrystal Pharma, Inc. · Stock Options (Right to Buy)A Award	10% Owner	AAward	+1.71M sh	—	—	1,706,978
2008-01-01	Pharmasset IncG Gift	10% Owner	GGift	−596K sh	—	—	595,516

Recent filings

Accepted (ET)
May 124
Schinazi Raymond F0001209191-22-028445
SEC(opens sec.gov)
May 124
Schinazi Raymond F0001209191-21-032018
SEC(opens sec.gov)
May 64
Schinazi Raymond F0001493152-21-010669
SEC(opens sec.gov)
May 154
Schinazi Raymond F0001209191-20-029688
SEC(opens sec.gov)
Oct 294
Schinazi Raymond F0001493152-19-016105
SEC(opens sec.gov)
Apr 24
Schinazi Raymond F0001209191-19-022658
SEC(opens sec.gov)
Mar 294
Schinazi Raymond F0001209191-19-021848
SEC(opens sec.gov)
Sep 244
Schinazi Raymond F0001493152-18-013665
SEC(opens sec.gov)
May 144
Schinazi Raymond F0001493152-18-006784
SEC(opens sec.gov)
May 74
Schinazi Raymond F0001493152-18-006360
SEC(opens sec.gov)

Companies

Address

2881 PEACHTREE ROAD, # 2204

ATLANTA, GA, 30305